Health Dictionary Find a Doctor

Nordazepam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Overview

Nordazepam (marketed under brand names Stilny®, Madar®, Vegesan®, and Calmday®), also known as nordiazepam and desmethyldiazepam, is a 1,4-benzodiazepine derivative. Like other benzodiazepine derivatives, it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties. However, it is used primarily in the treatment of anxiety. It is an active metabolite of diazepam, chlordiazepoxide, clorazepate, prazepam, and medazepam.[1]

Side effects

Side effects

Common side effects of nordazepam include somnolence, which is more common in elderly patients and/or people on high dose regimens. Hypotonia, which is much less common, is also associated with high doses and/or old age.

Interactions

Interactions

Benzodiazepines including N-desmethyldiazepam (nordazepam) may inhibit the glucuronidation of morphine leading to increased levels of and prolongation of the effects of morphine.[2]

Abuse

Abuse

Nordazepam and other sedative hypnotic drugs are detected frequently in cases of people suspected of driving under the influence of drugs. Other benzodiazepines and zolpidem and zopiclone are also found in high numbers of suspected drugged drivers. Many drivers have blood levels far exceeding the therapeutic dose range suggesting a high degree of abuse potential for benzodiazepines and zolpidem and zopiclone.[3]

External links
References

References

  1. Biam. “NORDAZEPAM” (in French). Retrieved 18 October. Unknown parameter |refyear= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Check date values in: |accessdate= (help)
  2. Pacifici GM (1986). “Metabolic interaction between morphine and various benzodiazepines”. Acta Pharmacol Toxicol (Copenh). 58 (4): 249–52. PMID 2872767. Unknown parameter |coauthors= ignored (help); Unknown parameter |month= ignored (help)
  3. Jones AW (2007). “Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results”. Ther Drug Monit. 29 (2): 248–60. PMID 17417081. Unknown parameter |coauthors= ignored (help); Unknown parameter |month= ignored (help)

Template:Benzodiazepines Template:Anxiolytics


Template:Pharma-stub

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH